EA025381B1 - Способ и промежуточные соединения, полезные для получения производных 2-карбоксамид циклоаминомочевины - Google Patents

Способ и промежуточные соединения, полезные для получения производных 2-карбоксамид циклоаминомочевины Download PDF

Info

Publication number
EA025381B1
EA025381B1 EA201391267A EA201391267A EA025381B1 EA 025381 B1 EA025381 B1 EA 025381B1 EA 201391267 A EA201391267 A EA 201391267A EA 201391267 A EA201391267 A EA 201391267A EA 025381 B1 EA025381 B1 EA 025381B1
Authority
EA
Eurasian Patent Office
Prior art keywords
formula
compound
stage
reaction mixture
compounds
Prior art date
Application number
EA201391267A
Other languages
English (en)
Russian (ru)
Other versions
EA201391267A1 (ru
Inventor
Бернхард Эрб
Изабель Силвье Галлу
Флориан Карл Кляйнбек
Original Assignee
Новартис Аг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45787206&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA025381(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Новартис Аг filed Critical Новартис Аг
Publication of EA201391267A1 publication Critical patent/EA201391267A1/ru
Publication of EA025381B1 publication Critical patent/EA025381B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/26—Radicals substituted by halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/16—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
EA201391267A 2011-03-03 2012-03-01 Способ и промежуточные соединения, полезные для получения производных 2-карбоксамид циклоаминомочевины EA025381B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161448774P 2011-03-03 2011-03-03
PCT/EP2012/053559 WO2012117071A1 (en) 2011-03-03 2012-03-01 Synthesis of 2-carboxamide cycloamino urea derivatives

Publications (2)

Publication Number Publication Date
EA201391267A1 EA201391267A1 (ru) 2014-01-30
EA025381B1 true EA025381B1 (ru) 2016-12-30

Family

ID=45787206

Family Applications (4)

Application Number Title Priority Date Filing Date
EA201391267A EA025381B1 (ru) 2011-03-03 2012-03-01 Способ и промежуточные соединения, полезные для получения производных 2-карбоксамид циклоаминомочевины
EA201792068A EA032802B1 (ru) 2011-03-03 2012-03-01 Производное пиридина, пригодное для синтеза ингибитора pi3k
EA201691331A EA201691331A1 (ru) 2011-03-03 2012-03-01 Способ получения органических соединений
EA201892052A EA201892052A1 (ru) 2011-03-03 2012-03-01 Способ получения органических соединений

Family Applications After (3)

Application Number Title Priority Date Filing Date
EA201792068A EA032802B1 (ru) 2011-03-03 2012-03-01 Производное пиридина, пригодное для синтеза ингибитора pi3k
EA201691331A EA201691331A1 (ru) 2011-03-03 2012-03-01 Способ получения органических соединений
EA201892052A EA201892052A1 (ru) 2011-03-03 2012-03-01 Способ получения органических соединений

Country Status (33)

Country Link
US (3) US9650373B2 (enExample)
EP (1) EP2681192B1 (enExample)
JP (1) JP6022485B2 (enExample)
KR (1) KR101851421B1 (enExample)
CN (2) CN106083840B (enExample)
AR (2) AR088714A1 (enExample)
AU (1) AU2012222346B2 (enExample)
BR (1) BR112013021882A2 (enExample)
CA (1) CA2828509C (enExample)
CL (1) CL2013002521A1 (enExample)
CO (1) CO6751286A2 (enExample)
DK (1) DK2681192T3 (enExample)
EA (4) EA025381B1 (enExample)
EC (1) ECSP13012914A (enExample)
ES (1) ES2663717T3 (enExample)
GT (1) GT201300211A (enExample)
HU (1) HUE036319T2 (enExample)
IL (1) IL228023A (enExample)
MA (1) MA34982B1 (enExample)
MX (2) MX351740B (enExample)
MY (1) MY163214A (enExample)
NO (1) NO2681192T3 (enExample)
PE (1) PE20140917A1 (enExample)
PH (1) PH12013501796A1 (enExample)
PL (1) PL2681192T3 (enExample)
PT (1) PT2681192T (enExample)
SG (1) SG192793A1 (enExample)
SI (1) SI2681192T1 (enExample)
TN (1) TN2013000354A1 (enExample)
TW (2) TWI597279B (enExample)
UA (1) UA112539C2 (enExample)
WO (1) WO2012117071A1 (enExample)
ZA (1) ZA201306174B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA112539C2 (uk) * 2011-03-03 2016-09-26 Новартіс Аг Спосіб одержання похідних 2-карбоксамідциклоаміносечовини
EP3218349A2 (en) * 2014-11-14 2017-09-20 Gemphire Therapeutics Inc. Processes and intermediates for preparing , -dicarboxylic acid-terminated dialkane ethers
EP3612171A4 (en) 2017-04-18 2020-10-21 Gemphire Therapeutics Inc. GEMCABENE, PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, COMPOSITIONS THEREOF AND PROCEDURES FOR THE USE OF THE SAME
CN112961090A (zh) * 2019-12-13 2021-06-15 武汉九州钰民医药科技有限公司 合成Alpelisib的关键中间体及其制备方法
CN110964005A (zh) * 2019-12-16 2020-04-07 武汉九州钰民医药科技有限公司 一种Alpelisib的制备工艺
CN111057051A (zh) * 2019-12-16 2020-04-24 武汉九州钰民医药科技有限公司 PI3K抑制剂Alpelisib的新合成方法
KR20220125753A (ko) 2021-03-05 2022-09-14 배성륭 기능성 풍력 발전시스템
CN119462487A (zh) * 2023-08-08 2025-02-18 重庆博腾制药科技股份有限公司 一种阿培利司中间体4-甲基吡啶类化合物的制备方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004096797A1 (en) * 2003-05-02 2004-11-11 Novartis Ag Inhibitors of phosphatidylinositol 3-kinase
WO2007087427A2 (en) * 2006-01-25 2007-08-02 Synta Pharmaceuticals Corp. Thiazole and thiadiazole compounds for inflammation and immune-related uses
WO2010029082A1 (en) * 2008-09-10 2010-03-18 Novartis Ag Organic compounds

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3534056A (en) * 1967-03-02 1970-10-13 Pennwalt Corp Fluoro-alkyl pyridines and their preparation
UA60365C2 (uk) 1998-06-04 2003-10-15 Пфайзер Продактс Інк. Похідні ізотіазолу, спосіб їх одержання, фармацевтична композиція та спосіб лікування гіперпроліферативного захворювання у ссавця
MXPA02002559A (es) 1999-09-10 2002-07-30 Merck & Co Inc Inhibidores de tirosina cinasa.
TWI428091B (zh) 2007-10-23 2014-03-01 Du Pont 殺真菌劑混合物
JP2011506560A (ja) * 2007-12-20 2011-03-03 ノバルティス アーゲー Pi3キナーゼ阻害剤として用いられるチアゾール誘導体
WO2009080649A2 (en) * 2007-12-21 2009-07-02 Telefonaktiebolaget Lm Ericsson (Publ) Improvements in or relating to wireless mobility
UA112539C2 (uk) * 2011-03-03 2016-09-26 Новартіс Аг Спосіб одержання похідних 2-карбоксамідциклоаміносечовини

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004096797A1 (en) * 2003-05-02 2004-11-11 Novartis Ag Inhibitors of phosphatidylinositol 3-kinase
WO2007087427A2 (en) * 2006-01-25 2007-08-02 Synta Pharmaceuticals Corp. Thiazole and thiadiazole compounds for inflammation and immune-related uses
WO2010029082A1 (en) * 2008-09-10 2010-03-18 Novartis Ag Organic compounds

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
SARKIS G Y, AL-AZAWE S: "PREPARATION AND SPECTRAL CHARACTERIZATION OF SUBSTITUTED 2-AMINOTHIAZOLES", JOURNAL OF CHEMICAL AND ENGINEERING DATA., AMERICAN CHEMICAL SOCIETY., US, vol. 18, no. 01, 1 January 1973 (1973-01-01), US, pages 99 - 102, XP009056608, ISSN: 0021-9568 *

Also Published As

Publication number Publication date
US9776966B2 (en) 2017-10-03
US9650373B2 (en) 2017-05-16
KR101851421B1 (ko) 2018-04-23
US20170240509A1 (en) 2017-08-24
KR20140009432A (ko) 2014-01-22
PT2681192T (pt) 2018-04-02
EP2681192A1 (en) 2014-01-08
PL2681192T3 (pl) 2018-06-29
SG192793A1 (en) 2013-09-30
CL2013002521A1 (es) 2014-02-14
CN103402982B (zh) 2016-07-13
AU2012222346A1 (en) 2013-08-29
CA2828509C (en) 2018-11-20
IL228023A (en) 2017-04-30
ES2663717T3 (es) 2018-04-16
ZA201306174B (en) 2014-05-28
CN106083840B (zh) 2020-01-03
CN106083840A (zh) 2016-11-09
TW201247660A (en) 2012-12-01
EP2681192B1 (en) 2017-12-27
MA34982B1 (fr) 2014-03-01
MX351740B (es) 2017-10-26
EA201892052A1 (ru) 2019-02-28
US10059670B2 (en) 2018-08-28
JP2014511387A (ja) 2014-05-15
SI2681192T1 (en) 2018-04-30
NZ614173A (en) 2015-04-24
GT201300211A (es) 2014-12-30
US20170355677A1 (en) 2017-12-14
NO2681192T3 (enExample) 2018-05-26
CO6751286A2 (es) 2013-09-16
UA112539C2 (uk) 2016-09-26
MX2013010132A (es) 2013-10-30
TW201722916A (zh) 2017-07-01
AR123584A2 (es) 2022-12-21
JP6022485B2 (ja) 2016-11-09
TWI607994B (zh) 2017-12-11
ECSP13012914A (es) 2013-11-29
CA2828509A1 (en) 2012-09-07
DK2681192T3 (en) 2018-04-16
TN2013000354A1 (en) 2015-01-20
MX347348B (es) 2017-04-17
MY163214A (en) 2017-08-30
AR088714A1 (es) 2014-07-02
BR112013021882A2 (pt) 2016-07-19
TWI597279B (zh) 2017-09-01
EA201792068A3 (ru) 2018-05-31
PE20140917A1 (es) 2014-08-14
EA201391267A1 (ru) 2014-01-30
HUE036319T2 (hu) 2018-06-28
EA032802B1 (ru) 2019-07-31
EA201792068A2 (ru) 2018-01-31
WO2012117071A1 (en) 2012-09-07
US20130331579A1 (en) 2013-12-12
IL228023A0 (en) 2013-09-30
PH12013501796A1 (en) 2022-10-26
AU2012222346B2 (en) 2015-05-07
CN103402982A (zh) 2013-11-20
EA201691331A1 (ru) 2017-01-30

Similar Documents

Publication Publication Date Title
US9776966B2 (en) Synthesis of 2-carboxamide cycloamino urea derivatives
IL151533A (en) Cyclic amide derivatives and medicaments and sigma ligands thereof
JP2010530405A (ja) Gabaモジュレーターとして有用な縮合キノリン誘導体
CN109496213A (zh) 螺环化合物及其制备和使用方法
KR20180049056A (ko) 삼환식 축합피리딘-2-온 유도체 및 이들의 brd4 저해제로서의 용도
JP7685522B2 (ja) 新規アクリジニウム塩およびその製造方法
CN106892926B (zh) 一种dpp-iv抑制剂的中间体、其制备方法和通过其制备dpp-iv抑制剂的方法
Alberola et al. Synthesis of [1] benzopyrano [4, 3-b] pyrrol-4 (1H)-ones from 4-chloro-3-formylcoumarin
HK1189578B (en) Synthesis of 2-carboxamide cycloamino urea derivatives
HK1189578A (en) Synthesis of 2-carboxamide cycloamino urea derivatives
WO2001017947A1 (en) Process for the preparation of 2,3-dihydroazepine compounds
NZ614173B2 (en) Synthesis of 2-carboxamide cycloamino urea derivatives
CN121620521A (zh) 抗冠状病毒化合物及其组合物和用途
HK1127775A (en) Substituted cinnoline derivatives as gabaa-receptor modulators and method for their synthesis
MXPA00010234A (en) Method for producing enantiomer-free n-methyl-n- [(1s)-1-phenyl- 2-((3s)- 3-hydroxypyrrolidine- 1-yl)ethyl]- 2,2-diphenyl acetamide

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): BY

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): KZ